Hispanic/Latinx immigrants have high obesity rates, yet they participate less in weight management interventions. This cross-sectional online study recruited Hispanic/ Latinx immigrants living in the United States (US). In a within-subject experimental crossover component, participants were presented with brief information about a hypothetical weight management intervention that was culturally adapted for Hispanics/ Latinx, or a standard intervention (not adapted) and asked about their willingness to enroll.
View Article and Find Full Text PDFNon-prescription weight loss substances, such as supplements and herbal remedies, can be harmful. Hispanic immigrant students may be highly susceptible to these substances, especially those advertised on social media. This study was a feasibility/acceptability pilot trial of an intervention to reduce this susceptibility.
View Article and Find Full Text PDFObjective: Treatment of obesity has been transformed by the recent approval of incretin-based therapies for weight loss (e.g., glucagon-like peptide 1 agonist semaglutide), but little is known about patient perspectives on these medications.
View Article and Find Full Text PDFBackground: For individuals who are eligible but unlikely to join comprehensive weight loss programs, a low burden self-weighing intervention may be a more acceptable approach to weight management.
Methods: This was a single-arm feasibility trial of a 12-month self-weighing intervention. Participants were healthcare patients with a BMI ≥25 kg/m with a weight-related comorbidity or a BMI >30 kg/m who reported lack of interest in joining a comprehensive weight loss program, or did not enroll in a comprehensive program after being provided program information.
Most adults with obesity do not enrol in comprehensive weight loss interventions when offered. For these individuals, lower burden self-weighing interventions may offer an acceptable alternative, though data is lacking on the potential for reach and representativeness of such interventions. Health system patients with BMI ≥30 kg/m (or 25-30 kg/m with an obesity comorbidity) completed a general health survey.
View Article and Find Full Text PDF